nafamostat has been researched along with Bacterial Infections in 4 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Bacterial Infections: Infections by bacteria, general or unspecified.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsintaurocholate-induced acute pancreatitis were studied in rats." | 7.70 | Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. ( Hayakawa, T; Ishiguro, H; Kitagawa, M; Naruse, S; Ozaki, T; Seki, Y; Wang, Y, 2000) |
| "Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsintaurocholate-induced acute pancreatitis were studied in rats." | 3.70 | Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. ( Hayakawa, T; Ishiguro, H; Kitagawa, M; Naruse, S; Ozaki, T; Seki, Y; Wang, Y, 2000) |
| "We divided 84 patients with acute necrotizing pancreatitis into two groups, CRAI (-) and CRAI (+), and compared the outcome." | 1.34 | Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. ( Ajiki, T; Fujino, Y; Fujita, T; Kuroda, Y; Matsumoto, I; Nakajima, T; Sakai, T; Sawa, H; Shinzeki, M; Takeyama, Y; Ueda, T; Yasuda, T, 2007) |
| "30% at 24 hours), and bacterial infection of the peritoneal fluid, mesenteric lymph nodes, and pancreas was completely prevented in group III." | 1.31 | Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model. ( Isaji, S; Takagi, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, T | 1 |
| Ueda, T | 1 |
| Takeyama, Y | 1 |
| Shinzeki, M | 1 |
| Sawa, H | 1 |
| Nakajima, T | 1 |
| Matsumoto, I | 1 |
| Fujita, T | 1 |
| Sakai, T | 1 |
| Ajiki, T | 1 |
| Fujino, Y | 1 |
| Kuroda, Y | 1 |
| Yanagihara, Y | 1 |
| Shida, T | 1 |
| Takagi, K | 1 |
| Isaji, S | 1 |
| Naruse, S | 1 |
| Wang, Y | 1 |
| Kitagawa, M | 1 |
| Ishiguro, H | 1 |
| Seki, Y | 1 |
| Ozaki, T | 1 |
| Hayakawa, T | 1 |
4 other studies available for nafamostat and Bacterial Infections
| Article | Year |
|---|---|
Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Benzamidines; Biopsy, Fine-Needle; Drug Therapy, Combin | 2007 |
[Immunopharmacological actions of 6-amidino-2-naphthyl-4-guanidinobenzoate (FUT-175). 1. Effect of FUT-175 on immune response and host defense in mice].
Topics: Animals; Antibody Formation; Bacterial Infections; Benzamidines; Guanidines; Immunity; Lymphocytes; | 1983 |
Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model.
Topics: Acute Disease; Amylases; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocati | 2000 |
Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Topics: Acute Disease; Animals; Bacterial Infections; Benzamidines; Colony Count, Microbial; Escherichia col | 2000 |